ChemicalBook > Product Catalog >API >Antipyretic analgesics >Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) >Bufexamac

Bufexamac

Bufexamac Structure
CAS No.
2438-72-4
Chemical Name:
Bufexamac
Synonyms
j3;cp1044;feximac;mofenar;parfenac;droxaryl;droxarol;cp1044j3;flogicid;norfemac
CBNumber:
CB7768637
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
MOL File:
2438-72-4.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:17

Bufexamac Properties

Melting point 153-155°
Boiling point 364.56°C (rough estimate)
Density 1.1223 (rough estimate)
refractive index 1.5300 (estimate)
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Practically insoluble in water, soluble in dimethylformamide, slightly soluble in ethyl acetate and in methanol.
form Solid
pka 9.24±0.20(Predicted)
color White to Off-White
Merck 14,1474
CAS DataBase Reference 2438-72-4(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H317
Precautionary statements  P261-P272-P280-P302+P352+P333+P313+P363-P501
WGK Germany  2
RTECS  AK8280000
HS Code  2928.00.2500
Toxicity LD50 orally in mice, rats: >8, >4 g/kg (Lambelin)

Bufexamac price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) B0760 Bufexamac analytical standard 2438-72-4 10G ₹10262.1 2022-06-14 Buy
TCI Chemicals (India) B4179 Bufexamac 2438-72-4 5G ₹4600 2022-05-26 Buy
Product number Packaging Price Buy
B0760 10G ₹10262.1 Buy
B4179 5G ₹4600 Buy

Bufexamac Chemical Properties,Uses,Production

Chemical Properties

White Solid

Uses

Bufexamac is a specific inhibitor of class IIB histone deacetylases (HDAC6 and HDAC10). Bufexamac is a non-steroidal anti-inflammatory drug used topically as well as rectally. Formulations containing Bufexamac is used by many patients with eczematous disorders as an alternative to topical corticosteroids.

Definition

ChEBI: A hydroxamic acid derived from phenylacetamide in which the benzene moiety is substituted at C-4 by a butoxy group. It has anti-inflammatory, analgesic, and antipyretic properties.

World Health Organization (WHO)

Bufexamac, an analgesic and anti-inflammatory agent, was introduced in 1974 for the topical treatment of a wide range of dermatoses. The drug is widely marketed and the World Health Organization is not aware of restrictive action having been taken elsewhere.

Contact allergens

Bufexamac is an arylacetic nonsteroidal anti-inflammatory drug. It induces allergic contact dermatitis, eczematous or erythema multiforme like type, and even generalized eruptions like acute generalized exanthematous pustulosis.

Bufexamac Preparation Products And Raw materials

Global( 250)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry
TCI Chemicals (India) Pvt. Ltd. 1800 425 7889 New Delhi, India 6778 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics & Synthetics (P) Ltd. 91-172-5066494 Haryana, India 631 58 Inquiry
Innovative Synthetic Molecules +91 40-24111684 Hyderabad, India 527 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Kebee Pharmachemie Pvt., Ltd. 91-22-28328669 Maharashtra, India 65 58 Inquiry
Vyshno Bio Sciences 91-7095439993 Hyderabad, India 239 58 Inquiry

Bufexamac Spectrum

2-(p-butoxyphenyl)-acetohydroxamicaci 4-butoxy-n-hydroxy-benzeneacetamid 4-butoxy-n-hydroxybenzeneacetamide 4-butoxyphenylacetohydroxamicacid acidep-butoxyphenylacethydroxamique bufexamicacid cp1044 cp1044j3 droxarol droxaryl parfenac p-butoxyphenylacetohydroxamicacid AURORA KA-853 BUFEXAMAC 2-(4-BUTOXYPHENYL)-N-HYDROXYACETAMIDE LABOTEST-BB LT00134645 2-(p-butoxyphenyl)acetohydroxamic acid 2-(4-butoxyphenyl)acetohydroxamic acid 4-Butoxyphenylacethydroxamic acid p-Butoxyphenylacethydroxamic acid 2-(p-Butoxyphenyl)acetohydoroximic acid 2-(4-butoxyphenyl)ethanehydroxamic acid 2-(4-butoxyphenyl)-N-hydroxy-ethanamide Bufexamac, >=98% feximac flogicid flogocidnplastigel j3 malipuran mofenar norfemac Bufexamac, 98%, a COX inhibitor tantalum(2+) Bufexamac CRS Bufexamac > Benzeneacetamide, 4-butoxy-N-hydroxy- Bufexamac USP/EP/BP Bufexamac (Bufexamic acid) Bufexamac, ≥ 98.0% 2438-72-4 C12H17NO3 Analytical Standards Alphabetic Analytical Chromatography Product Catalog BI - BZ API NORFEMAC Chemistry Miscellaneous Lipid signaling